BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12670265)

  • 21. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
    Wen X; Jackson EF; Price RE; Kim EE; Wu Q; Wallace S; Charnsangavej C; Gelovani JG; Li C
    Bioconjug Chem; 2004; 15(6):1408-15. PubMed ID: 15546209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gadolinium(III) complexes of 1,4,7-triazacyclononane based picolinate ligands: simultaneous optimization of water exchange kinetics and electronic relaxation.
    Nonat A; Giraud M; Gateau C; Fries PH; Helm L; Mazzanti M
    Dalton Trans; 2009 Oct; (38):8033-46. PubMed ID: 19771367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Facile synthesis and relaxation properties of novel bispolyazamacrocyclic Gd3+ complexes: an attempt towards calcium-sensitive MRI contrast agents.
    Mishra A; Fousková P; Angelovski G; Balogh E; Mishra AK; Logothetis NK; Tóth E
    Inorg Chem; 2008 Feb; 47(4):1370-81. PubMed ID: 18166011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NMR transversal relaxivity of aqueous suspensions of particles of Ln(3+)-based zeolite type materials.
    Pereira GA; Norek M; Peters JA; Ananias D; Rocha J; Geraldes CF
    Dalton Trans; 2008 May; (17):2241-7. PubMed ID: 18414747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The gadolinium(III)-water hydrogen distance in MRI contrast agents.
    Caravan P; Astashkin AV; Raitsimring AM
    Inorg Chem; 2003 Jun; 42(13):3972-4. PubMed ID: 12817950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Separation and characterization of the two diastereomers for [Gd(DTPA-bz-NH2)(H2O)]2-, a common synthon in macromolecular MRI contrast agents: their water exchange and isomerization kinetics.
    Burai L; Tóth E; Sour A; Merbach AE
    Inorg Chem; 2005 May; 44(10):3561-8. PubMed ID: 15877439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of CH3-DTPA-Gd (NMS60) as a new MR contrast agent: early phase II study in brain tumors and dual dynamic contrast-enhanced imaging.
    Ito M; Ogino H; Oshima H; Shiraki N; Shibamoto Y; Kasai H; Mase M; Kawamura Y; Miyati T
    Magn Reson Imaging; 2006 Jun; 24(5):625-30. PubMed ID: 16735185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the strong field dependence and nonlinear response to gadolinium contrast agent of proton transverse relaxation rates in dairy cream.
    Mulkern RV; Hung YP; Ababneh Z; Maier SE; Packard AB; Uluer MC; Kacher DF; Gambarota G; Voss S
    Magn Reson Imaging; 2005 Jul; 23(6):757-64. PubMed ID: 16198831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, potentiometric, kinetic, and NMR Studies of 1,4,7,10-tetraazacyclododecane-1,7-bis(acetic acid)-4,10-bis(methylenephosphonic acid) (DO2A2P) and its complexes with Ca(II), Cu(II), Zn(II) and lanthanide(III) ions.
    Kálmán FK; Baranyai Z; Tóth I; Bányai I; Király R; Brücher E; Aime S; Sun X; Sherry AD; Kovács Z
    Inorg Chem; 2008 May; 47(9):3851-62. PubMed ID: 18380456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of small degree of nonuniformity in dialysate flow in hollow-fiber dialyzer using proton magnetic resonance imaging.
    Osuga T; Obata T; Ikehira H
    Magn Reson Imaging; 2004 Apr; 22(3):417-20. PubMed ID: 15062938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human comparative study of zinc and copper excretion via urine after administration of magnetic resonance imaging contrast agents.
    Kimura J; Ishiguchi T; Matsuda J; Ohno R; Nakamura A; Kamei S; Ohno K; Kawamura T; Murata K
    Radiat Med; 2005 Aug; 23(5):322-6. PubMed ID: 16342903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton magnetic resonance imaging of diffusion of high- and low-molecular-weight contrast agents in opaque porous media saturated with water.
    Osuga T; Han S
    Magn Reson Imaging; 2004 Sep; 22(7):1039-42. PubMed ID: 15288146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of relaxivity rates of Gd-DTPA complexes by intercalation into layered double hydroxide nanoparticles.
    Xu ZP; Kurniawan ND; Bartlett PF; Lu GQ
    Chemistry; 2007; 13(10):2824-30. PubMed ID: 17186555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Equilibrium signal intensity mapping, an MRI method for fast mapping of longitudinal relaxation rates and for image enhancement.
    Surányi P; Kiss P; Ruzsics B; Brott BC; Simor T; Elgavish GA
    Magn Reson Imaging; 2007 Jun; 25(5):641-51. PubMed ID: 17540275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of a tartaric acid derived polymeric MRI contrast agent to a small molecule model chelate.
    Lucas RL; Benjamin M; Reineke TM
    Bioconjug Chem; 2008 Jan; 19(1):24-7. PubMed ID: 18092744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design of Gd(III)-based magnetic resonance imaging contrast agents: static and transient zero-field splitting contributions to the electronic relaxation and their impact on relaxivity.
    Benmelouka M; Borel A; Moriggi L; Helm L; Merbach AE
    J Phys Chem B; 2007 Feb; 111(4):832-40. PubMed ID: 17249827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Equilibrium and kinetic properties of the lanthanoids(III) and various divalent metal complexes of the heptadentate ligand AAZTA.
    Baranyai Z; Uggeri F; Giovenzana GB; Bényei A; Brücher E; Aime S
    Chemistry; 2009; 15(7):1696-705. PubMed ID: 19130509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of human serum albumin on longitudinal and transverse relaxation rates (r1 and r2) of magnetic resonance contrast agents.
    Giesel FL; von Tengg-Kobligk H; Wilkinson ID; Siegler P; von der Lieth CW; Frank M; Lodemann KP; Essig M
    Invest Radiol; 2006 Mar; 41(3):222-8. PubMed ID: 16481904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability, water exchange, and anion binding studies on lanthanide(III) complexes with a macrocyclic ligand based on 1,7-diaza-12-crown-4: extremely fast water exchange on the Gd3+ complex.
    Pálinkás Z; Roca-Sabio A; Mato-Iglesias M; Esteban-Gómez D; Platas-Iglesias C; de Blas A; Rodríguez-Blas T; Tóth E
    Inorg Chem; 2009 Sep; 48(18):8878-89. PubMed ID: 19655713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calix[4]arenes as molecular platforms for magnetic resonance imaging (MRI) contrast agents.
    Schühle DT; Schatz J; Laurent S; Vander Elst L; Muller RN; Stuart MC; Peters JA
    Chemistry; 2009; 15(13):3290-6. PubMed ID: 19206118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.